Non-Thyroidal Illness Syndrome in Critically Ill Children: Prognostic Value and Impact of Nutritional Management.

INTRODUCTION Non-thyroidal illness (NTI), which occurs with fasting and in response to illness, is characterized by thyroid hormone inactivation with low triiodothyronine (T3) and high reverse T3 (rT3), followed by suppressed thyrotropin (TSH). Withholding supplemental parenteral nutrition early in pediatric critical illness (late-PN), thus accepting low/no macronutrient intake up to day 8 in the pediatric intensive care unit (PICU), accelerated recovery compared to initiating supplemental parenteral nutrition early (early-PN). Whether NTI is harmful or beneficial in pediatric critical illness and how it is affected by a macronutrient deficit remains unclear. This study investigated the prognostic value of NTI, the impact of late-PN on NTI, and whether such impact explains or counteracts the outcome benefit of late-PN in critically ill children. METHODS This preplanned secondary analysis of the Early versus Late Parenteral Nutrition in the Pediatric Intensive Care Unit randomized controlled trial quantified serum TSH, total thyroxine (T4), T3, and rT3 concentrations in 982 patients upon PICU admission versus 64 matched healthy children and in 772 propensity score-matched early-PN and late-PN patients upon admission and at day 3 or last PICU day for shorter PICU stay. Associations between thyroid hormone concentrations upon admission and outcome, as well as impact of late-PN on NTI in relation with outcome, were assessed with univariable analyses and multivariable logistic regression, linear regression, or Cox proportional hazard analysis, adjusted for baseline risk factors. RESULTS Upon PICU admission, critically ill children revealed lower TSH, T4, T3, and T3/rT3 and higher rT3 than healthy children (p < 0.0001). A more pronounced NTI upon admission, with low T4, T3, and T3/rT3 and high rT3 was associated with higher mortality and morbidity. Late-PN further reduced T4, T3, and T3/rT3 and increased rT3 (p ≤ 0.001). Statistically, the further lowering of T4 by late-PN reduced the outcome benefit (p < 0.0001), whereas the further lowering of T3/rT3 explained part of the outcome benefit of late-PN (p ≤ 0.004). This effect was greater for infants than for older children. CONCLUSION In critically ill children, the peripheral inactivation of thyroid hormone, characterized by a decrease in T3/rT3, which is further accentuated by low/no macronutrient intake, appears beneficial. In contrast, the central component of NTI attributable to suppressed TSH, evidenced by the decrease in T4, seems to be a harmful response to critical illness. Whether treating the central component with TSH releasing hormone infusion in the PICU is beneficial requires further investigation.

[1]  E. Fliers,et al.  Regulation of Intracellular Triiodothyronine Is Essential for Optimal Macrophage Function. , 2018, Endocrinology.

[2]  S. Irving,et al.  Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Pediatric Critically Ill Patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[3]  Patrick C Hanley,et al.  Thyroid Disorders in Children and Adolescents: A Review. , 2016, JAMA pediatrics.

[4]  T. Kirby Early versus late parenteral nutrition in critically ill children. , 2016, The Lancet. Respiratory medicine.

[5]  G. Van den Berghe,et al.  Worldwide Survey of Nutritional Practices in PICUs* , 2016, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[6]  G. Van den Berghe On the Neuroendocrinopathy of Critical Illness. Perspectives for Feeding and Novel Treatments. , 2016, American journal of respiratory and critical care medicine.

[7]  E. Fliers,et al.  Thyroid function in critically ill patients. , 2015, The lancet. Diabetes & endocrinology.

[8]  Long-Term Neurodevelopmental Outcome of Children Treated with Tri-Iodothyronine after Cardiac Surgery: Follow-Up of a Double-Blind, Randomized, Placebo-Controlled Study , 2015, Hormone Research in Paediatrics.

[9]  G. Van den Berghe,et al.  Impact of withholding early parenteral nutrition completing enteral nutrition in pediatric critically ill patients (PEPaNIC trial): study protocol for a randomized controlled trial , 2015, Trials.

[10]  N. Paneth,et al.  Thyroid hormone supplementation in preterm infants born before 28 weeks gestational age and neurodevelopmental outcome at age 36 months. , 2014, Thyroid : official journal of the American Thyroid Association.

[11]  C. Fekete,et al.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions. , 2014, Endocrine reviews.

[12]  G. Van den Berghe,et al.  Impact of early nutrient restriction during critical illness on the nonthyroidal illness syndrome and its relation with outcome: a randomized, controlled clinical study. , 2013, The Journal of clinical endocrinology and metabolism.

[13]  G. Van den Berghe,et al.  Effect of tight glucose control with insulin on the thyroid axis of critically ill children and its relation with outcome. , 2012, The Journal of clinical endocrinology and metabolism.

[14]  G. Van den Berghe,et al.  Contribution of nutritional deficit to the pathogenesis of the nonthyroidal illness syndrome in critical illness: a rabbit model study. , 2012, Endocrinology.

[15]  D. Kouvelas,et al.  Effect of early compared with delayed enteral nutrition on endocrine function in patients with traumatic brain injury: an open-labeled randomized trial. , 2012, JPEN. Journal of parenteral and enteral nutrition.

[16]  G. Van den Berghe,et al.  Early versus Late Parenteral Nutrition in Critically Ill Adults , 2011, The New England journal of medicine.

[17]  N. Verhoeven,et al.  Metabolic Profiles in Children During Fasting , 2011, Pediatrics.

[18]  M. Falagas,et al.  Association between thyroid function tests at baseline and the outcome of patients with sepsis or septic shock: a systematic review. , 2011, European journal of endocrinology.

[19]  Habshah Midi,et al.  Collinearity diagnostics of binary logistic regression model , 2010 .

[20]  W. Hop,et al.  Dutch national survey to test the STRONGkids nutritional risk screening tool in hospitalized children. , 2010, Clinical nutrition.

[21]  P. Mitchell,et al.  Challenges to optimal enteral nutrition in a multidisciplinary pediatric intensive care unit. , 2010, JPEN. Journal of parenteral and enteral nutrition.

[22]  J. Stockigt,et al.  Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. , 2009, Best practice & research. Clinical endocrinology & metabolism.

[23]  I. Rebeyka,et al.  Hypothalamic-pituitary-thyroid axis changes in children after cardiac surgery. , 2009, The Journal of clinical endocrinology and metabolism.

[24]  M. Agus,et al.  Thyroid function in the critically ill newborn and child , 2009, Current opinion in pediatrics.

[25]  Greet Van den Berghe,et al.  Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study , 2009, The Lancet.

[26]  E. Fliers,et al.  Type 3 deiodinase is highly expressed in infiltrating neutrophilic granulocytes in response to acute bacterial infection. , 2008, Thyroid : official journal of the American Thyroid Association.

[27]  T. Visser,et al.  Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock , 2008, Clinical endocrinology.

[28]  E. Fliers,et al.  Fasting-induced changes in the hypothalamus-pituitary-thyroid axis. , 2008, Thyroid : official journal of the American Thyroid Association.

[29]  D. Tibboel,et al.  HORMONE LEVELS IN CHILDREN DURING THE FIRST WEEK OF ICU-ADMISSION: IS THERE AN EFFECT OF ADEQUATE FEEDING? , 2005, Clinical nutrition.

[30]  P. D. del Nido,et al.  A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. , 2005, The Journal of thoracic and cardiovascular surgery.

[31]  Stephen A. Huang Physiology and pathophysiology of type 3 deiodinase in humans. , 2005, Thyroid : official journal of the American Thyroid Association.

[32]  G. Van den Berghe,et al.  Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. , 2005, The Journal of clinical endocrinology and metabolism.

[33]  W. Hop,et al.  Thyroid function and outcome in children who survived meningococcal septic shock , 2005, Intensive Care Medicine.

[34]  M. Şırlak,et al.  Oral thyroid hormone pretreatment in left ventricular dysfunction. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[35]  F. Zegher,et al.  Dopamine suppresses pituitary function in infants and children , 1994, Pediatric Nephrology.

[36]  Alain Martinot,et al.  Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study , 2003, The Lancet.

[37]  G. Van den Berghe,et al.  Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. , 2003, The Journal of clinical endocrinology and metabolism.

[38]  F. Shann,et al.  PIM2: a revised version of the Paediatric Index of Mortality , 2003, Intensive Care Medicine.

[39]  G. Van den Berghe,et al.  The combined administration of GH‐releasing peptide‐2 (GHRP‐2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP‐2 alone , 2002, Clinical endocrinology.

[40]  G. Umpierrez Euthyroid sick syndrome. , 2002, Southern medical journal.

[41]  I. Klein,et al.  A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. , 2001, The Journal of thoracic and cardiovascular surgery.

[42]  D. Osborn Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. , 2001, The Cochrane database of systematic reviews.

[43]  V. Kyriazopoulou,et al.  Dissociation of the early decline in serum T(3) concentration and serum IL-6 rise and TNFalpha in nonthyroidal illness syndrome induced by abdominal surgery. , 2001, The Journal of clinical endocrinology and metabolism.

[44]  G. Rosenthal,et al.  Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. , 2000, Journal of Thoracic and Cardiovascular Surgery.

[45]  M. Bettendorf,et al.  Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study , 2000, The Lancet.

[46]  G. Berghe Euthyroid sick syndrome. , 2000 .

[47]  G. Van den Berghe,et al.  Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.

[48]  A. Dugbartey Neurocognitive aspects of hypothyroidism. , 1998, Archives of internal medicine.

[49]  G. Van den Berghe,et al.  Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. , 1998, The Journal of clinical endocrinology and metabolism.

[50]  E. Fliers,et al.  Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. , 1997, The Journal of clinical endocrinology and metabolism.

[51]  M. Bettendorf,et al.  Transient Secondary Hypothyroidism in Children after Cardiac Surgery , 1997, Pediatric Research.

[52]  S. Thomas,et al.  Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.

[53]  R. Utiger Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? , 1995, The New England journal of medicine.

[54]  G. Zucchelli,et al.  Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass. , 1995, The Annals of thoracic surgery.

[55]  P. Rothwell,et al.  Thyrotropin concentration predicts outcome in critical illness , 1993, Anaesthesia.

[56]  K. Ouchi,et al.  Effects of supplementary parenteral nutrition on thyroid hormone patterns in surgical patients with liver cirrhosis. , 1991, Nutrition.

[57]  J. Zimmerman,et al.  Thyroid hormone metabolism and level of illness severity in pediatric cardiac surgery patients. , 1989, The Journal of pediatrics.

[58]  H. Westh,et al.  Pituitary-thyroid axis in critical illness. , 1987, The Journal of clinical endocrinology and metabolism.

[59]  O. Neyzi,et al.  Thyroid function in critically ill infants with infections , 1986, Pediatric infectious disease.

[60]  G. Brent,et al.  Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. , 1986, The Journal of clinical endocrinology and metabolism.

[61]  A. Mason,et al.  Hypermetabolic low triiodothyronine syndrome of burn injury , 1982, Critical care medicine.

[62]  M. Lesch,et al.  Sudden death associated with thyroid hormone abuse. , 1981, The American journal of medicine.

[63]  T. O'donnell,et al.  Altered thyroid hormone levels in bacterial sepsis: the role of nutritional adequacy. , 1980, Metabolism: clinical and experimental.

[64]  T. Brown,et al.  Fasting plasma glucose in children , 1980, Australian paediatric journal.